FibroGen logo

FibroGen

FGEN | NASDAQ
Chart Builder DCF Calculator
$9.07
-$0.15 (-1.63%)
At close: Jan 12, 2026, 09:30 AM ET
-1.63%

Rating

Updated: Sep 25, 2026
58
Fundamentals Strong
Market Sentiment Neutral
Moat None

Key Statistics

Market Data

Market Cap $36.69M
1D Range
9.02 9.21
52W Range
4.85 21.95

Valuation (TTM)

PE 0.20
PB -4.51
EV/EBITDA 1.45

Valuation (NTM)

Forward PE N/A
Forward PEG 0.00
Price Target $28.00
Loading financial charts...

Profile

FibroGen, Inc. is a biopharmaceutical firm dedicated to discovering, developing, and bringing to market therapies that address significant medical conditions currently lacking effective treatments. Am...

Sector Healthcare
Industry Biotechnology
Employees 225
IPO Date Nov 14, 2014
Fiscal Year January - December

Latest News

No news articles available yet.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.